• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 3. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. Agricultural
  Analyst, 1947,72, 170-172

Professional Introduction to 4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole (CAS No. 2225141-43-3)

4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole is a heterocyclic compound featuring a pyrazole core substituted with bromine, chlorine, and trifluoromethyl groups. This molecular structure imparts unique electronic and steric properties, making it a valuable intermediate in pharmaceutical and agrochemical research. The compound’s chemical formula can be represented as C?H?BrClF?N?, reflecting its composition of carbon, hydrogen, bromine, chlorine, fluorine, and nitrogen atoms.

The significance of 4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole lies in its versatility as a building block for synthesizing more complex molecules. Pyrazole derivatives are widely studied due to their biological activity, which includes antiviral, antibacterial, and anti-inflammatory properties. The presence of halogen substituents enhances the reactivity of the compound, allowing for further functionalization through cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings.

In recent years, researchers have explored the potential of 4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole in developing novel therapeutic agents. For instance, studies have demonstrated its utility in generating pyrazole-based inhibitors targeting enzymes involved in metabolic disorders. The trifluoromethyl group, in particular, is known to improve metabolic stability and binding affinity in drug candidates. This has led to increased interest in optimizing synthetic routes to achieve higher yields and purities of the compound.

The incorporation of both bromine and chlorine atoms into the pyrazole ring provides multiple sites for selective modifications. This feature is particularly advantageous in medicinal chemistry, where precise control over substitution patterns is crucial for achieving desired pharmacological effects. Researchers have leveraged these attributes to design libraries of derivatives for high-throughput screening (HTS) campaigns aimed at identifying lead compounds for drug development.

Advances in computational chemistry have further enhanced the study of 4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole by enabling accurate modeling of its interactions with biological targets. Molecular docking simulations have been employed to predict binding affinities and identify potential drug-like properties. These computational approaches complement experimental efforts by providing rapid assessments of structural modifications and their impact on activity.

The agrochemical sector has also benefited from the use of 4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole as a precursor for developing novel pesticides. Pyrazole-based compounds exhibit herbicidal and fungicidal activities, making them effective against a broad spectrum of pests. The halogenated derivatives enhance bioavailability and environmental stability, which are critical factors in agricultural applications.

Recent innovations in synthetic methodologies have focused on improving the scalability of producing 4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole. Catalytic processes and green chemistry principles have been applied to minimize waste and reduce energy consumption during synthesis. Such advancements align with global efforts to promote sustainable chemical manufacturing practices.

The role of 4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole in material science is another emerging area of interest. Its electronic properties make it a candidate for use in organic semiconductors and optoelectronic devices. Researchers are investigating its potential in fabricating light-emitting diodes (LEDs) and photovoltaic cells due to its ability to absorb visible light efficiently.

Future research directions may explore the use of 4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole in designing next-generation therapeutics targeting cancer and neurodegenerative diseases. The compound’s structural motifs are reminiscent of known bioactive scaffolds, suggesting its potential as a scaffold-hopping agent capable of modulating multiple disease pathways.

In conclusion,4-bromo-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole (CAS No. 2225141-43-3) represents a multifaceted compound with applications spanning pharmaceuticals, agrochemicals, and materials science. Its unique structural features offer opportunities for innovation across multiple disciplines, driven by ongoing advancements in synthetic chemistry and computational biology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)